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1. Introduction 
Calmodulin was originally characterised as the cal- 
cium-dependent activator of brain cyclic nucleotide 
phosphodiesterase. Subsequently it was shown to be 
the modulator of a variety of calcium-dependent cel- 
lular activities (reviews [l-3]). Calmodulin is now 
recognised as being a highly conserved and widely dis- 
tributed protein, having been demonstrated in many 
vertebrates and invertebrates [3,4], plants and higher 
fungi [5,6] as well as several unicellular eukaryotes; 
e.g., Dictyostelium discoideum [7], Blastocladiella 
emersonii [8], Euglena gracilis and Amoeba proteus 
[9]. Prokaryotes, in contrast,appear to lack calmodulin 
[6,7] although (exogenous) calmodulin has been 
shown to activate the adenylate cyclase of Bordetella 
pertussis [lo]. The observed distribution of calmodulin 
has led to the suggestion that it is ubiquitous in 
eukaryotes [3,5]. However, the inability of several 
laboratories to detect calmodulin in yeast [6,7,1 l] is 
in conflict with this assertion. This paper reports the 
presence of a calmodulln-like protein in extracts of 
the yeasts Candida albicans and Saccharomyces 
cerevisiae. The demonstration of this protein appears 
to be dependent on the use of the protease inhibitor, 
PMSF. 
2. Materials and methods 
2 .I . Materials 
Fluphenazine .2 HCl was kindly supplied by E. R. 
Squibb and Sons. TFP was a generous gift of Smith, 
Abbreviations: TFP, trifluoperazine;PMSF, phenyimethyl- 
sulfonylfluoride; SDS-PAGE, sodium dodecyl sulphate- 
polyacrylamide gel electrophoresis 
Kline and French Labs. PMSF and bovine brain phos- 
phodiesterase were obtained from Sigma. Protein 
A-Sepharose was purchased from Pharmacia. 
2.2. Cells 
Yeast cells of C. albicans (ATCC 10261), prepared 
in shake cultures as in [ 121, were harvested at late 
exponential phase. Fresh S. cerevisiue cells were 
obtained from a local brewery. 
2.3. Preparation of extracts 
All operations were performed at 4’C. Washed 
yeast cells were resuspended in 3 vol. homogenisation 
buffer (10 mM Tris-HCl, 2 mM EDTA (pH 7.5) with 
0.6 mM PMSF added from a freshly prepared stock in 
95% ethanol) and disrupted in a Braun homogeniser. 
The homogenate was centrifuged (6000 X g, 10 min) 
and the supernatant heated (85-9O”C, 2 min) then 
chilled. Precipitated proteins were removed by cen- 
trifugation (39 000 X g, 10 min) and further PMSF 
(0.3 mM) added. Acid ammonium sulphate fractiona- 
tion of the supernatant was performed as in [ 131. 
Extracts were dialysed against distilled water and 
stored at -20°C. 
2.4. Fluphenazine-Sepharose affinity chromatography 
Fluphenazine was coupled to Sepharose4B 
(200 ml) as in [5]. Affinity chromatography was per- 
formed as for peanut calmodulin [5] with the follow- 
ing modifications: the column buffer was 10 mM 
Tris-HCl @H 7.5), 0.5 mM CaCl,; the salt wash was 
0.1 M NaCl in column buffer; the elution buffer was 
10 mM Tris-HCl, 10 mM EGTA (pH 8.0); chroma- 
tography was performed at 4°C. The extracts were‘ 
made 0.5 mM in free Ca’+ and ialysed against column 
buffer prior to loading. Free Ca2+ concentration was 
computed as in [ 141. 
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2 5. Antibodies to calmodulin 
Rabbit antiserum to performic acid-oxidised ovine 
brain cahnodulin was raised as in [ 151 and the IgG 
fraction isolated by affinity chromatography on pro- 
tein A-Sepharose [ 161. Passive haemagglutination 
assays were performed as in [ 171 using glutaraldehyde 
as the coupling agent. 
2.6. Other methods 
Human erythrocyte Ca” t Mg2+-ATPase and 
regulator-deficient bovine brain 3’5’.cyclic nucleotide 
phosphodiesterase were assayed for calmodulinacti- 
vation as in [ 18,191. Calmodulin was isolated from 
ovine brain using affinity chromatography of heat- 
treated, acid ammonium sulphate fractionated extracts, 
with conditions essentially as above. Protein concen- 
tration was estimated by microassay [20] with BSA 
as a standard. Continuous PAGE was performed in 
10% gels (2.63% cross-linked) in the presence and 
absence of SDS (0.1%) [21]. Protein was stained with 
Coomassie blue. 
3. Results and discussion 
The heat stability of calmodulin permits rapid prep- 
aration of enriched cell-free extracts which can be 
assessed for calmodulin content by assaying with 
established calmodulin-regulated enzymes [l-4 J. Our 
preliminary analysis of heat-treated extracts prepared 
from C. albicans in the presence of PMSF indicated 
that they were capable of activating 2 calmodulin- 
regulated enzymes, Ca2+ + Mg2+-ATPase and brain 
phosphodiesterase, in a Ca2+-dependent manner. This 
calmodulin-like activity was not detected in extracts 
prepared in the absence of PMSF. Accordingly, PMSF 
was routinely used in ail subsequent extraction pro- 
cedures. 
Acid ammonium sulphate fractionation of heat- 
treated extracts of C. albicans, following a procedure 
used for calmodulin [13],‘preserved the calmodulin- 
like activity. SDS-PAGE of this fraction revealed 
several major protein species, including one than comi- 
grated with ovine brain calmodulin (fig.1). Likewise, 
in the absence of SDS, PAGE revealed a protein band 
that comigrated with calmodulin. Protein eluted from 
this band activated brain phosphodiesterase in the 
same manner as calmodulin (table 1). 
These findings indicated that the yeast activator 
had both physical and biological similarity to cal- 
86 
modulin. Affinity chromatography was therefore 
attempted. Fractionation of heat-treated C. albicans 
extracts on fluphenazine-Sepharose following the 
procedure used for peanut calmodulin [5] resulted in 
low protein yields at the EGTA elution (cahnodulin) 
step. Modifying the procedure as in section 2 increased 
Fig.1. SDS-PAGE of protein fractions: ovine brain calmodulin, 
10 yg (1); acid ammonium sulphate fraction of C. QibiCQnS, 
80 pg (2) and S. cerevisiae, 80 pg (4); C. dbicans protein 
fraction eluted from fluphenazine-Sepharose with EGTA, 
15 /Jg (3). 
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Table 1 
Activation of bovine brain phosphodiesterase by cahnodulin and yeast protein fractions 
January 1982 
Fraction Phosphodiesterase activity (nmol CAMP hydrolysed . min-’ : mg enzyme-‘) 
Basal A+ A-k Activation A + 
activitya protein 
fractionb 
protein (-fold) protein fraction + 
(A) fraction + Cal+ Cal+ + TFP 
Ovine brain calmodulin 0.90 0.90 2.90 3.2 0.95 
C. albicans proteinC 0.80 0.85 3.15 3.7 1.10 
PAGE eluated 0.70 ‘0.70 2.20 3.1 0.90 
a Activity of phosphodiesterase under standard assay conditions [ 191 in the absence of activator fraction. 
Values are the mean of at least duplicate experiments with variation of <lo% 
b Where indicated the following were added: protein fraction, 5 I.rg; free Ca’+, 1 mM; TFP, 20 PM 
c Protein fraction eluted from fluphenazine-Sepharose with EGTA 
d Protein fraction eluted from band corresponding in mobility to cahnodulin after PAGE (in absence of SDS) 
of acid ammonium sulphate fractionated C. albicans extract 
the yield and the protein fraction obtained gave over 
a 3-fold activation of brain phosphodiesterase, in the 
presence of Ca2+ (table 1). This activation was inhib- 
ited by EGTA and the calmodulin-inhibitory drug 
[22], TFP. SDS-PAGE revealed one major protein 
species, that comlgrated with calmodulin (fig.1). Pre- 
liminary immunologic analysis of this semi-pure cal- 
modulin-like protein, using the passive haemagglutina- 
tion technique indicated complete immunoreactivity 
with the anti-calmodulin IgG preparation. Using the 
procedure described for C. albicans, we found that a 
heat-treated extract of S. cerevisiae provided 2.5-fold 
activation of brain phosphodiesterase. This activation 
was Ca2’-dependent and TFP-sensitive. SDS-PAGE 
of the acid ammonium sulphate fraction revealed a 
protein band that comigrated with calmodulin (fig.1). 
These findings indicate the presence of a calmodulin- 
like protein in the yeasts C’. albicans and S. cerevisiae. 
The previous inability to detect calmoclulin in yeast 
(S. cerevisiae) [6,7,1 l] may have been due to inade- 
quate precautions being taken against proteolysis. 
Proteolytic artefacts are a particular problem in the 
biochemistry of yeast, and are due to their high con- 
tent of endogenous proteases [23]. PMSF is an effective 
inhibitor of yeast proteases B and C, while EDTA 
interferes with exopeptidase activity by chelating diva- 
lent cations. Maintenance of neutral pH inhibits pro- 
tease A activity and, at the same time, favours the 
formation of endogenous protease-protease inhibitor 
complexes. Protease content is lowest in actively 
growing cells [23]. All of these measures were taken 
as a precaution against proteolysis here; in particular, 
the use of PMSF appeared to be critical. 
The salient characteristics of the C’. albicans cal- 
modulin-like protein are its: heat stability; acidic 
nature; activation of 2 calmodulin-regulated enzymes 
in a Ca2’-dependent, TFP-sensitive manner; Ca2+- 
dependent binding to fluphenazine; comigration with 
calmodulin during PAGE; immunoreactivity with 
anti-calmodulin IgG. Although further criteria are 
required before this protein can be absolutely classified 
as a ‘calmodulln’ [24], the now likely existence of 
calmodulin in yeast supports the concept [3_,5] that 
calmodulin is ubiquitous in eukaryotes. Apart from 
being of evolutionary interest, further Investigation of 
yeast calmodulin is warranted because of the obvious 
advantages associated with the study of these geneti- 
cally and metabolically well-characterised organisms. 
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